Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
PharmaEssentia Corp.
ISIN TW0006446008
|WKN A2DHCL
Market cap (in EUR)
8,276 m
Country
Taiwan
Sector
Healthcare
Dividend yield
0.12%
Overview
Description
PharmaEssentia Corp. engages in the research, development, production and sale of drugs. Its business activities include the manufacture and sale of therapeutic products for the treatment of human diseases. The company was founded by Kuo Chung Lin on May 9, 2000 and is headquartered in Taipei, Taiwan.
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals Taiwan
Financials
Key metrics
| Market capitalisation, EUR | 8,276 m |
| EPS, EUR | 0.45 |
| P/B ratio | 8.6 |
| P/E ratio | 49.8 |
| Dividend yield | 0.12% |
Income statement (2025)
| Revenue, EUR | 445 m |
| Net income, EUR | 144 m |
| Profit margin | 32.27% |
What ETF is PharmaEssentia Corp. in?
There are 14 ETFs which contain PharmaEssentia Corp.. All of these ETFs are listed in the table below. The ETF with the largest weighting of PharmaEssentia Corp. is the iShares MSCI Taiwan UCITS ETF.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.